Investigational Site 003 — New York, New York

Investigational Site 003 is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site 003 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Recurrent Pericarditis, Heart Diseases, Pericarditis.

Sponsors: Kiniksa Pharmaceuticals International, plc.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 003?

Investigational Site 003 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 003 conducted?

Investigational Site 003 has 1 clinical trials on record, with 1 currently active. Their work covers Recurrent Pericarditis, Heart Diseases, Pericarditis.

Is Investigational Site 003 accredited by Crixeo Health?

Investigational Site 003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.